Kenneth L. Davis, MD
President and Chief Executive Officer
Mount Sinai Health System

Election of New Members to the Boards of Trustees

I am pleased to announce the election of Amaziah Howell, the Honorable William C. Thompson, Jr., and David Wheadon, MD, to the Mount Sinai Health System Boards of Trustees for terms expiring in 2024.

Amaziah “Bill” Howell is the President of Howell Petroleum Products, which he founded in 1985 as a Texaco wholesale oil distributor. Today, the organization provides construction management services and mentoring to small minority and women business enterprise contractors in New York City.

Mr. Howell’s career has been committed to increasing diversity in the construction, education, and finance industries. As the Chair of the School of Construction Authority Advisory Board, he led a successful effort to increase the number of African American and Hispanic leaders in senior management positions, and as the Chairman of the Downtown Brooklyn Advisory and Oversight Committee, he facilitated the awarding of contracts totaling more than $200 million to minority and women-owned businesses. He has also contributed to legislation calling for the first-ever equity financing for minority-owned businesses and helped develop Article 15-A, New York State’s Minority and Women Business Enterprises policy. Mr. Howell is on the Fundraising Committee for One Hundred Black Men and is a Deacon at Cornerstone Baptist Church in Brooklyn. He previously served on the boards of the Helen Keller Foundation, Boys and Girls Clubs of Brooklyn, and many others.

The Honorable William C. Thompson, Jr., is a dedicated advocate for innovation, diversity, and progress in the public and private sectors. He is a Partner at Siebert Williams Shank & Co., one of the largest minority and women-owned investment banks in the United States, and has served as Chief Administrative Officer since April 2010.

Mr. Thompson served two consecutive four-year terms as the Comptroller of the City of New York beginning in 2002. He served five terms as the President of the New York City Board of Education, with oversight of the nation’s largest school system. He is the Chair of the Board of The City University of New York for the term ending in 2022. In addition to serving on the boards of many museums, schools, libraries, and other organizations, he was also recently appointed to the New York Forward Reopening Advisory Board to guide the state’s reopening during the pandemic. Mr. Thompson is a former board member of the Bedford-Stuyvesant Restoration Corporation, which was founded by his father, William Thompson, with Robert F. Kennedy.

David Wheadon, MD, is a psychiatrist with more than 30 years of experience in clinical development, public policy, and regulatory affairs. He has been integral to the development and approval of several drugs for central nervous system diseases, diabetes, gastrointestinal disorders, and other diseases.

Dr. Wheadon most recently served as Senior Vice President of Global Regulatory Affairs, Patient Safety, and Quality Assurance at AstraZeneca Pharmaceuticals. He previously held senior regulatory and clinical development leadership positions at Abbott, GlaxoSmithKline, Eli Lilly, the Juvenile Diabetes Research Foundation, and the Pharmaceutical Research Manufacturers of America. Dr. Wheadon is a board member of Karuna Therapeutics and ConnectiveRx, and previously served as a board member of the Make-A-Wish Foundation of America and the Executive Board for the National Institutes of Health. He is a longtime member of the American Academy of Pharmaceutical Physicians and the American Psychiatric Association. He completed his medical degree at Johns Hopkins University and his psychiatry fellowship at Tufts New England Medical Center.
I am delighted to have these outstanding leaders join our community at a vital time in the history of our institution. We are committed to developing a leadership team, including the Board of Trustees, that is not only representative of our patients and larger community, but one that takes action to improve diversity, equity, and inclusion in the Mount Sinai community and beyond.